文献速递乳房整形与再造美容整形

乳房再造美学效果评估的当前概念与新兴技术

Current Concepts and Emerging Technologies in Aesthetic Outcome Assessment of Breast Reconstruction.
PubMed 文献 · Aesthet Surg J · 2026-01-01

该系统综述纳入2000至2025年间51项研究、共7711名来自16个国家的参与者,评估植入物、自体或混合乳房再造后的美学效果。主观工具以BREAST-Q最常用(69%),客观方法包括三维表面成像(16%)、BCCT.core(14%)、眼动追踪(6%)和人工智能分析(6%)。BREAST-Q仍是结局评估的基石,但尚无单一模态能全面覆盖所有美学维度,未来需整合主客观评估于统一框架。

要点

  • BREAST-Q是乳房再造后美学评估最常用的主观工具(69%)。
  • 客观评估以三维表面成像(16%)和BCCT.core(14%)为主。
  • 无单一模态能全面覆盖所有美学维度,需多模态整合。

核心结论

  • BREAST-Q仍是乳房再造后结局评估的基石,提供以患者为中心的视角。
  • 美学评估正逐步转向多模态评估,未来需将主客观方法整合于统一框架。

研究设计与样本

  • 系统综述,检索2000至2025年间评估植入物、自体或混合乳房再造后美学效果的研究。
  • 共纳入51项研究,涉及16个国家的7711名参与者。
  • 采用Joanna Briggs Institute Critical Appraisal Checklist评估偏倚风险,并按牛津循证医学中心标准分级证据。

主要发现

  • 主观工具最常用:BREAST-Q(35/51,69%)、专家或小组评估(17/51,33%)、视觉模拟量表(2/51,4%)。
  • 客观方法应用于19项研究:三维表面成像(8/51,16%)、BCCT.core(7/51,14%)、眼动追踪(3/51,6%)、人工智能分析(3/51,6%)。
  • 主观工具捕捉对乳房外观的满意度,客观工具量化形态参数和位置标志。

关键数值与推荐

  • BREAST-Q使用率35/51(69%),专家或小组评估17/51(33%),视觉模拟量表2/51(4%)。
  • 三维表面成像8/51(16%),BCCT.core 7/51(14%),眼动追踪3/51(6%),人工智能分析3/51(6%)。

临床怎么用

  • 临床评估乳房再造美学效果时可优先使用BREAST-Q获取患者报告结局。
  • 可结合三维表面成像或BCCT.core等客观工具量化形态参数。
  • 尚无单一模态覆盖所有美学维度,宜采用多模态评估策略。

局限性

  • 证据水平为3级(治疗性)。
  • 未报告各研究的偏倚风险具体结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Aesthetic outcomes are a crucial determinant of the overall success of breast reconstruction. Recently, aesthetic assessment has evolved from relying mainly on subjective impressions to incorporating more quantitative methods. This systematic review summarizes current concepts and emerging technologies in aesthetic outcome assessment after breast reconstruction. A comprehensive search of studies evaluating aesthetic outcomes following implant-based, autologous or hybrid breast reconstruction was performed between 2000 and 2025. Assessments were classified as subjective or objective. Extracted variables included assessment characteristics, aesthetic outcome domains, and patient-centered outcomes. Risk of bias was assessed using the Joanna Briggs Institute Critical Appraisal Checklist. Levels of evidence were classified according to the Oxford Centre for Evidence-Based Medicine. A total of 51 studies involving 7711 participants from 16 countries were included. Subjective tools were most frequently employed, led by the BREAST-Q (35/51, 69%), followed by expert- or panel-based evaluations (17/51, 33%) and the visual analog scale (2/51, 4%). Objective methods were applied in 19 studies and included 3-dimensional surface imaging (8/51, 16%), BCCT.core (7/51, 14%), eye tracking (3/51, 6%), and artificial intelligence-based analyses (3/51, 6%). Although subjective tools captured satisfaction with breast appearance, objective tools quantified morphological parameters and positional landmarks. BREAST-Q remains the cornerstone of outcome evaluation after breast reconstruction, providing patient-centered perspectives, including, but not limited to, aesthetic perception. A progressive shift toward multimodal evaluation was noticed, as no single modality comprehensively addressed all aesthetic domains. Future research should focus on integrating subjective and objective assessment methods within a unified framework. Level of Evidence: 3 (Therapeutic) For image description, please refer to the figure legend and surrounding text.

来源:Aesthet Surg J,查看原文。版权归原作者所有。

引用

  1. Lyu D, Vollbach FH, Mesas Aranda I, et al. Current Concepts and Emerging Technologies in Aesthetic Outcome Assessment of Breast Reconstruction. Aesthet Surg J. 2026. PMID: 42159042. doi:10.1093/asj/sjag101

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。